DrugDev Hosts New Educational Webinar, “The ROI and Best Practices of Outsourcing Investigator Payments” May 14
KING OF PRUSSIA, PA and LONDON, UK (PRWEB) May 07, 2015 -- DrugDev will present an educational webinar, “The ROI and Best Practices of Outsourcing Investigator Payments” on May 14, 2015 featuring Stuart Thiede, President of DrugDev Payments and April Mulroney, Vice President of Tax Services at DrugDev. The free webinar features an interactive and evidence-based discussion that provides actionable advice to improve your investigator payment process and a model to evaluate the ROI of your payment solution.
Webinar: The ROI and Best Practices of Outsourcing Investigator Payments
Date: May 14, 2015
Time: 10:00-11:00am EDT
CLICK TO REGISTER
This webinar is complimentary
Across therapeutic areas, one of the primary frustrations of clinical sites – and a key reason why many investigators elect not to participate in future trials – is the inefficient and unreliable payment process. But how can sponsors and CROs prove the value of their outsourcing decision?
This complimentary webinar evaluates outsourcing with an ROI model that measures real-world metrics such as operational efficiencies, investigator relationships, financial management and compliance. Expert presenters will also discuss actionable best practices (e.g. global tax optimization) to ensure sponsors and CROs get the most from their internal or outsourced solution. The webinar will feature a live Q&A session with attendees and a recording will be provided to everyone who registers.
About the Presenters
Stu Thiede, President, Payments, DrugDev – Stu leads the highly skilled and experienced professionals who deliver investigator grant payment services to clinical trial sponsors and CROs. Stu brings nearly 30 years of experience from companies that provide technology solutions to their clients, with 10 years of this experience specific to companies providing software and professional service solutions to the pharmaceutical industry. His diverse background includes significant executive roles in finance, operations, service delivery, and account management in enterprises ranging from a Fortune 500 technology company to a high-growth software and professional service mid-market company, to two small start-up enterprises.
April Mulroney, Vice President, Tax Services, DrugDev – April founded DrugDev’s Tax Services division that oversees the currency, tax, legal, and industry regulations in moving currency across all geographic regions for global clinical trials. She is experienced in supporting clinical trial financial accounting management, with a high proficiency in operational performance and business development. April has a strong accounting and finance foundation, holding certified accounting designations in North America and the U.K.
About DrugDev
DrugDev is an innovative technology company which provides cloud-based solutions to help sponsors, CROs and investigators do more clinical trials together. Built around the largest global network of active opted-in investigators, DrugDev’s unified solutions suite optimizes site selection and startup, investigator payments and clinical operations. DrugDev also serves as the trusted third-party host of the revolutionary Investigator Databank collaboration. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs rely on DrugDev technology to do more trials at drugdev.com.
Brenda Nashawaty, DrugDev, http://www.drugdev.com, +1 617-688-3253, [email protected]
Share this article